AT311564B - Verfahen zur Herstellung von neuen in 9α-Stellung unsubstituierten 6,11β-Dichlor-19-norsteroid-4-en (bzw. 4,6-dien)-3-onen - Google Patents

Verfahen zur Herstellung von neuen in 9α-Stellung unsubstituierten 6,11β-Dichlor-19-norsteroid-4-en (bzw. 4,6-dien)-3-onen

Info

Publication number
AT311564B
AT311564B AT851569A AT851569A AT311564B AT 311564 B AT311564 B AT 311564B AT 851569 A AT851569 A AT 851569A AT 851569 A AT851569 A AT 851569A AT 311564 B AT311564 B AT 311564B
Authority
AT
Austria
Prior art keywords
norsteroid
dichloro
diene
preparation
new
Prior art date
Application number
AT851569A
Other languages
German (de)
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Application granted granted Critical
Publication of AT311564B publication Critical patent/AT311564B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT851569A 1966-07-29 1967-07-28 Verfahen zur Herstellung von neuen in 9α-Stellung unsubstituierten 6,11β-Dichlor-19-norsteroid-4-en (bzw. 4,6-dien)-3-onen AT311564B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3427566 1966-07-29
GB23066/67A GB1202521A (en) 1966-07-29 1966-07-29 01beta-CHLORO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
AT311564B true AT311564B (de) 1973-11-26

Family

ID=26256295

Family Applications (2)

Application Number Title Priority Date Filing Date
AT851569A AT311564B (de) 1966-07-29 1967-07-28 Verfahen zur Herstellung von neuen in 9α-Stellung unsubstituierten 6,11β-Dichlor-19-norsteroid-4-en (bzw. 4,6-dien)-3-onen
AT706867A AT301766B (de) 1966-07-29 1967-07-28 Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT706867A AT301766B (de) 1966-07-29 1967-07-28 Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden

Country Status (12)

Country Link
JP (2) JPS5021469B1 (OSRAM)
AT (2) AT311564B (OSRAM)
BE (1) BE702023A (OSRAM)
CH (2) CH580644A5 (OSRAM)
DE (1) DE1668124B2 (OSRAM)
DK (2) DK129004B (OSRAM)
FR (2) FR1565340A (OSRAM)
GB (1) GB1202521A (OSRAM)
IL (1) IL28411A (OSRAM)
NL (1) NL6710459A (OSRAM)
PL (1) PL79253B1 (OSRAM)
SE (2) SE349025B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1289521A (OSRAM) * 1969-01-23 1972-09-20
GB1313659A (en) * 1969-07-25 1973-04-18 Glaxo Lab Ltd 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds
JPS5090183A (OSRAM) * 1973-12-14 1975-07-19
JPS5090184A (OSRAM) * 1973-12-14 1975-07-19

Also Published As

Publication number Publication date
SE350488B (OSRAM) 1972-10-30
BE702023A (OSRAM) 1968-01-29
AT301766B (de) 1972-09-25
JPS5224013B1 (OSRAM) 1977-06-28
DE1668124A1 (de) 1971-05-06
DK131295B (da) 1975-06-23
CH584724A5 (OSRAM) 1977-02-15
DK129004B (da) 1974-08-05
FR1565340A (OSRAM) 1969-05-02
DK131295C (OSRAM) 1975-11-17
CH580644A5 (OSRAM) 1976-10-15
GB1202521A (en) 1970-08-19
DE1668124B2 (de) 1976-10-07
SE349025B (OSRAM) 1972-09-18
NL6710459A (OSRAM) 1968-01-30
FR7812M (OSRAM) 1970-05-20
JPS5021469B1 (OSRAM) 1975-07-23
PL79253B1 (OSRAM) 1975-06-30
IL28411A (en) 1972-07-26

Similar Documents

Publication Publication Date Title
CH548365A (de) Verfahren zur herstellung von 3,4-dihydroxy-oder 3,4diocyloxyphenylalkanolaminen.
CH494222A (de) Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
AT290023B (de) Verfahren zur Herstellung von neuen 3-OA-11β-OB-13β-C-17α-R-17β-OE-gona-1,3,5(10)-trienen
CH519507A (de) Verfahren zur Herstellung von neuem 1-Veratryl-4-methyl-5-äthyl-7,8-dimethoxy-2,3-diazabicyclo(5.4.0)-undecapentaen-(1,3,6,8,10)
CH481924A (de) Verfahren zur Herstellung von 6-Aminophenyl- und 6-Acylaminophenyl-4,5-dihydropyridazonen (3)
AT281836B (de) Verfahren zur Herstellung von neuen 2-Methyl-3-carbonsäureamido-chinoxalin-di-N-oxiden-(1,4)
CH478828A (de) Verfahren zur Herstellung von neuen substituierten 3,1-Benzoxazin-2-onen
CH485775A (de) Verfahren zur Herstellung von 9-B-D-Ribofuranosyl-7-deazapurin-3',5'-cyclophosphaten
CH487096A (de) Verfahren zur Herstellung von 4,4'-Dohydroxy-stilbenen
CH481935A (de) Verfahren zur Herstellung von N-Acyl-3,4-dihydrooxazinen-(1,3)
AT281838B (de) Verfahren zur Herstellung von neuen 2-Isothiuronium-methyl-3-carbonsäureamido-chinoxalin-di-N-oxid-(1,4)-halogeniden
AT275758B (de) Verfahren zur Herstellung von neuen 4-Oxa-9β,10α-Steroiden
CH506548A (de) Verfahren zur Herstellung von 2-aminsubstituiertem 4,5-Diphenyl-Oxazol
AT275060B (de) Verfahren zur Herstellung von 1β-Hydroxy-5-oxo-4-(2'-carboxy-äthyl)-7aβ-R-3aα-4β,5,6,7,7a-hexahydroindanen
AT283356B (de) Verfahren zur Herstellung von neuen 1,2,4-Oxdiazolidin-Derivaten
CH490342A (de) Verfahren zur Herstellung von 2,6-Dicyan-4-nitranilin
AT292662B (de) Verfahren zur Herstellung von 1,1'-Peroxydicyclohexylamin
CH517756A (de) Verfahren zur Herstellung von neuen 11-Amino-5,6-dihydro-6-morphantridonen
AT281793B (de) Verfahren zur Herstellung von neuen 1-Amino-2-hydroxy-3-(2',3',5'-trimethyl-4'-hydroxy-bzw. acyloxy-phenoxy)-propanen
CH483434A (de) Verfahren zur Herstellung von 1,2-Dihydrobenzodiazepinen
AT266800B (de) Verfahren zur Herstellung von 2-Thiapropandiol-(1,3)
AT291967B (de) Verfahren zur Herstellung von neuen N-Phenyl-N-2-fluor-1,1,2,2,-tetrachloräthylsulfenyl-sulfamiden
CH478780A (de) Verfahren zur Herstellung von 3a,5-Cyclo-6B,19-oxido-5a-androstan-17-on.
AT268564B (de) Verfahren zur Herstellung von neuen Carbonaten des 3-Oxo-17β-hydroxyöstra-4,9,11-triens
CH557825A (de) Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee